Mostrar el registro sencillo del ítem

dc.contributor.author
Domene, Horacio Mario  
dc.contributor.author
Hwa, Vivian  
dc.contributor.author
Jasper, Hector Guillermo  
dc.contributor.author
Rosenfeld, Ron G.  
dc.date.available
2020-02-18T17:47:53Z  
dc.date.issued
2011-02  
dc.identifier.citation
Domene, Horacio Mario; Hwa, Vivian; Jasper, Hector Guillermo; Rosenfeld, Ron G.; Acid-labile subunit (ALS) deficiency; Elsevier; Best Practice & Research Clinical Endocrinology & Metabolism; 25; 1; 2-2011; 101-113  
dc.identifier.issn
1521-690X  
dc.identifier.uri
http://hdl.handle.net/11336/97911  
dc.description.abstract
The acid-labile subunit (ALS) protein is crucial for maintaining the integrity of the circulating IGF/IGFBP system. In humans, complete ALS deficiency is characterized by severely reduced serum IGF-I and IGFBP-3 concentrations that is incongruent with the associated mild growth retardation (height SDS -2 to -3 SDS before and during puberty). Twenty-one patients have been described with ALS deficiency, representing 16 unique homozygous or compound heterozygous inactivating mutations of the IGFALS gene. Pubertal delay in boys and insulin insensitivity are common findings. In the assessment of a child with short stature ALS deficiency should be consider in those patients presenting: 1) a normal response to GH stimulation test, 2) low IGF-I levels associated with more profoundly reduced IGFBP-3 levels, 3) a mild growth retardation, apparently out of proportion to the degree of IGF-I and IGFBP-3 deficits, 4) lack of response to an IGF generation test and 5) insulin insensitivity.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
ACID-LABILE SUBUNIT  
dc.subject
GROWTH HORMONE INSENSITIVITY  
dc.subject
IGFALS GENE MUTATIONS  
dc.subject
INSULIN-LIKE GROWTH FACTOR-I  
dc.subject
LNSULIN RESISTANCE  
dc.subject
LNSULIN-LIKE GROWTH FACTOR BINDING PROTEIN  
dc.subject.classification
Endocrinología y Metabolismo  
dc.subject.classification
Medicina Clínica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Acid-labile subunit (ALS) deficiency  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2020-02-07T13:49:07Z  
dc.journal.volume
25  
dc.journal.number
1  
dc.journal.pagination
101-113  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Amsterdam  
dc.description.fil
Fil: Domene, Horacio Mario. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de Endocrinología Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; Argentina  
dc.description.fil
Fil: Hwa, Vivian. Oregon Health & Science University; Estados Unidos  
dc.description.fil
Fil: Jasper, Hector Guillermo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de Endocrinología Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; Argentina  
dc.description.fil
Fil: Rosenfeld, Ron G.. Oregon Health & Science University; Estados Unidos  
dc.journal.title
Best Practice & Research Clinical Endocrinology & Metabolism  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S1521690X10000953  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.beem.2010.08.010